PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BUSE vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BUSE and PFE is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

BUSE vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Busey Corporation (BUSE) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

-15.00%-10.00%-5.00%0.00%5.00%SeptemberOctoberNovemberDecember2025February
-1.84%
-7.94%
BUSE
PFE

Key characteristics

Sharpe Ratio

BUSE:

0.33

PFE:

0.00

Sortino Ratio

BUSE:

0.72

PFE:

0.17

Omega Ratio

BUSE:

1.08

PFE:

1.02

Calmar Ratio

BUSE:

0.23

PFE:

0.00

Martin Ratio

BUSE:

1.12

PFE:

0.00

Ulcer Index

BUSE:

8.87%

PFE:

9.59%

Daily Std Dev

BUSE:

30.45%

PFE:

23.17%

Max Drawdown

BUSE:

-85.41%

PFE:

-54.82%

Current Drawdown

BUSE:

-32.72%

PFE:

-50.79%

Fundamentals

Market Cap

BUSE:

$1.42B

PFE:

$146.72B

EPS

BUSE:

$1.98

PFE:

$1.41

PE Ratio

BUSE:

12.57

PFE:

18.36

PEG Ratio

BUSE:

3.05

PFE:

0.18

Total Revenue (TTM)

BUSE:

$576.32M

PFE:

$63.63B

Gross Profit (TTM)

BUSE:

$439.94M

PFE:

$41.72B

EBITDA (TTM)

BUSE:

$37.74M

PFE:

$16.34B

Returns By Period

In the year-to-date period, BUSE achieves a 6.71% return, which is significantly higher than PFE's -0.80% return. Over the past 10 years, BUSE has outperformed PFE with an annualized return of 6.33%, while PFE has yielded a comparatively lower 1.69% annualized return.


BUSE

YTD

6.71%

1M

8.74%

6M

-1.84%

1Y

11.57%

5Y*

3.68%

10Y*

6.33%

PFE

YTD

-0.80%

1M

0.07%

6M

-7.93%

1Y

-0.28%

5Y*

-0.95%

10Y*

1.69%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BUSE vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BUSE
The Risk-Adjusted Performance Rank of BUSE is 5454
Overall Rank
The Sharpe Ratio Rank of BUSE is 5858
Sharpe Ratio Rank
The Sortino Ratio Rank of BUSE is 5151
Sortino Ratio Rank
The Omega Ratio Rank of BUSE is 4848
Omega Ratio Rank
The Calmar Ratio Rank of BUSE is 5656
Calmar Ratio Rank
The Martin Ratio Rank of BUSE is 5858
Martin Ratio Rank

PFE
The Risk-Adjusted Performance Rank of PFE is 4242
Overall Rank
The Sharpe Ratio Rank of PFE is 4545
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 3737
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 3636
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 4545
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 4545
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BUSE vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for First Busey Corporation (BUSE) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BUSE, currently valued at 0.33, compared to the broader market-2.000.002.000.330.00
The chart of Sortino ratio for BUSE, currently valued at 0.72, compared to the broader market-4.00-2.000.002.004.006.000.720.17
The chart of Omega ratio for BUSE, currently valued at 1.08, compared to the broader market0.501.001.502.001.081.02
The chart of Calmar ratio for BUSE, currently valued at 0.45, compared to the broader market0.002.004.006.000.450.00
The chart of Martin ratio for BUSE, currently valued at 1.12, compared to the broader market0.0010.0020.0030.001.120.00
BUSE
PFE

The current BUSE Sharpe Ratio is 0.33, which is higher than the PFE Sharpe Ratio of 0.00. The chart below compares the historical Sharpe Ratios of BUSE and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50SeptemberOctoberNovemberDecember2025February
0.33
0.00
BUSE
PFE

Dividends

BUSE vs. PFE - Dividend Comparison

BUSE's dividend yield for the trailing twelve months is around 3.90%, less than PFE's 6.53% yield.


TTM20242023202220212020201920182017201620152014
BUSE
First Busey Corporation
3.90%4.07%3.87%3.72%3.39%4.08%3.05%3.26%2.40%2.21%3.01%2.92%
PFE
Pfizer Inc.
6.53%6.33%5.70%3.12%2.64%3.91%3.68%3.12%3.53%3.69%3.47%3.34%

Drawdowns

BUSE vs. PFE - Drawdown Comparison

The maximum BUSE drawdown since its inception was -85.41%, which is greater than PFE's maximum drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for BUSE and PFE. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-10.65%
-50.79%
BUSE
PFE

Volatility

BUSE vs. PFE - Volatility Comparison

First Busey Corporation (BUSE) has a higher volatility of 8.53% compared to Pfizer Inc. (PFE) at 6.49%. This indicates that BUSE's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%SeptemberOctoberNovemberDecember2025February
8.53%
6.49%
BUSE
PFE

Financials

BUSE vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between First Busey Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab